» Authors » Elisabeth Rexen Ulven

Elisabeth Rexen Ulven

Explore the profile of Elisabeth Rexen Ulven including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 88
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Wargent E, Kepczynska M, Kaspersen M, Rexen Ulven E, Arch J, Ulven T, et al.
Br J Nutr . 2024 May; 132(1):13-20. PMID: 38751244
A healthy diet is at the forefront of measures to prevent type 2 diabetes. Certain vegetable and fish oils, such as pine nut oil (PNO), have been demonstrated to ameliorate...
2.
Ieremias L, Kaspersen M, Manandhar A, Schultz-Knudsen K, Vrettou C, Pokhrel R, et al.
J Med Chem . 2024 Feb; 67(5):3542-3570. PMID: 38381650
GPR84 is a putative medium-chain fatty acid receptor that is implicated in regulation of inflammation and fibrogenesis. Studies have indicated that GPR84 agonists may have therapeutic potential in diseases such...
3.
Dragano N, Milbank E, Haddad-Tovolli R, Garrido-Gil P, Novoa E, Fondevilla M, et al.
Mol Metab . 2023 Nov; 79:101840. PMID: 38036170
Objective: Free fatty acid receptor-1 (FFAR1) is a medium- and long-chain fatty acid sensing G protein-coupled receptor that is highly expressed in the hypothalamus. Here, we investigated the central role...
4.
Kjaer V, Stepniewski T, Medel-Lacruz B, Reinmuth L, Ciba M, Rexen Ulven E, et al.
Chem Sci . 2023 Oct; 14(39):10671-10683. PMID: 37829039
The G protein-coupled receptor GPR183 is a chemotactic receptor with an important function in the immune system and association with a variety of diseases. It recognizes ligands with diverse physicochemical...
5.
Ciba M, Dibnah B, Hudson B, Rexen Ulven E
J Med Chem . 2023 Jun; 66(13):8951-8974. PMID: 37318348
The succinate receptor (SUCNR1) has emerged as a potential target for the treatment of various metabolic and inflammatory diseases, including hypertension, inflammatory bowel disease, and rheumatoid arthritis. While several ligands...
6.
Lorza-Gil E, Kaiser G, Carlein C, Hoffmann M, Konig G, Haug S, et al.
Diabetologia . 2023 May; 66(8):1501-1515. PMID: 37217659
Aims/hypothesis: After birth, the neonatal islets gradually acquire glucose-responsive insulin secretion, a process that is subjected to maternal imprinting. Although NEFA are major components of breastmilk and insulin secretagogues, their...
7.
Valentini A, Schultz-Knudsen K, Hansen A, Tsakoumagkou A, Jenkins L, Christensen H, et al.
J Med Chem . 2023 May; 66(9):6105-6121. PMID: 37129317
The free fatty acid receptor 2 (FFA2), also known as GPR43, mediates effects of short-chain fatty acids and has attracted interest as a potential target for treatment of various metabolic...
8.
Barki N, Bolognini D, Borjesson U, Jenkins L, Riddell J, Hughes D, et al.
Elife . 2022 Mar; 11. PMID: 35229717
Volatile small molecules, including the short-chain fatty acids (SCFAs), acetate and propionate, released by the gut microbiota from the catabolism of nondigestible starches, can act in a hormone-like fashion via...
9.
Hansen A, Christensen H, Pandey S, Sergeev E, Valentini A, Dunlop J, et al.
ChemMedChem . 2021 Jul; 16(21):3326-3341. PMID: 34288488
Free fatty acid receptor 2 (FFA2) is a sensor for short-chain fatty acids that has been identified as an interesting potential drug target for treatment of metabolic and inflammatory diseases....
10.
Sorensen K, Korfitzen S, Kaspersen M, Rexen Ulven E, Ekberg J, Bauer-Brandl A, et al.
Clin Nutr . 2020 Oct; 40(4):2169-2179. PMID: 33059911
Bacground & Aim: Pinolenic acid, a major component (~20%) of pine nut oil, is a dual agonist of the free fatty acid receptors, FFA1 and FFA4, which may regulate release...